Organoids Market Size, Share, Scope, and Trends by 2031
The organoids market size is projected to reach US$ 15.01 billion by 2031 from US$ 3.03 billion in 2023. The market is expected to register a CAGR of 22.3% in 2023–2031. The combination of organoids and organ-on-a-chip is likely to act as one of the key trends in the organoids market in the future.
Organoids Market Analysis
Factors contributing to the organoids market growth include the increasing demand for tumor modeling and biobanking, and a surging adoption of personalized drugs. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids Market Overview
Organoids are microscopic and self-organized 3D structures derived in vitro from stem cells. They exhibit various structural and functional characteristics of their in vivo counterpart organs. This multipurpose technology has led to numerous new human cancer models. It is now possible to create indefinitely expanding organoids starting from the tumor tissue of individuals suffering from a variety of cancers. Alternatively, CRISPR-based gene modification allows the creation of cancer organoid models by introducing any combination of cancer gene modifications to normal organoids. Tumor organoids, when combined with immune cells and fibroblasts, generate a cancer microenvironment model that enables immune-oncology applications. Recent studies emphasize the significant role of organoids in personalized medicine approaches. Continuous advancements in organoid technology have enabled tumors and patient-centric 3D cultures of cells isolated from tumor biopsies. Organoids have been generated from breast, bladder, colon, prostate, pancreas, and liver cancer in humans over the past few decades. Studies involving these models help provide a clear overview of these malignancies. Tumoroid lines being introduced in vitro are opening new avenues for a range of downstream applications such as drug discovery and development and cancer research. Moreover, 3D-based cultures offer added advantages over conventional 2D cancer-derived cell lines.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Market: Strategic Insights
Market Size Value in US$ 2,507.28 million in 2022 Market Size Value by US$ 12,206.15 million by 2030 Growth rate CAGR 21.9% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Organoids Market: Strategic Insights
| Market Size Value in | US$ 2,507.28 million in 2022 |
| Market Size Value by | US$ 12,206.15 million by 2030 |
| Growth rate | CAGR 21.9% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Organoids Market Drivers and Opportunities
Surging Adoption of Personalized Drugs Favors Organoids Market
Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs that are tailored to the individual patient based on the anticipated response or disease risk. In a study published by the Personalized Medicine Coalition, the share of personalized medicines in the new FDA-approved molecular entities rose from 5% in 2005 to more than 25% in 2016. In addition, 37 new molecular entities (NMEs) were approved by the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) in 2022. 12 of these NMEs, i.e.~34%, were personalized medicine. Moreover, biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs, which is estimated to increase by 33% by 2027. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming years. According to a report published in 2021 by the Personalized Medicine Coalition, the number of personalized medicines in the US market grew from 132 in 2016 to 286 in 2020.
Focus on Drug Discovery Activities to Create Opportunities for Organoids Market Growth
The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2021 was estimated at 384,288. A recent survey by the HUB states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug and omitting them from clinical trials. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models. Organoids in drug discovery are not limited to just cancer; they are also used in other disease studies, including cystic fibrosis, polycystic kidney disease, microcephaly, and gut and airway infections. For instance, organoids can summarize the properties of an organ, such as organ structure and function. They can also restore the original genetic and epigenetic state of a tissue or an organ, making them suitable for gene editing. Thus, the continued focus on drug discovery activities to tap the untapped areas of medicine offers more significant growth opportunities for the organoids market.
Organoids Market Report Segmentation Analysis
Key segments that contributed to the derivation of the organoids market analysis are type, application, source, type, and method.
- Based on type, the organoids market is classified into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
- By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
- Based on source, the organoids market is divided into pluripotent stem cells and organ-specific adult stem cells. The microbial segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
- Based on offering, the organoids market is divided into instruments, consumables, and services. The consumables segment held the largest share of the market in 2023.
- Based on method, the organoids market is classified into micropatterned plates, ultralow attachment plates, hanging drop, microdroplet/emulsion, and others. The microbial segment held the largest share of the market in 2023. The hanging drop segment is anticipated to register the highest CAGR during the forecast period.
Organoids Market Share Analysis by Geography
The geographic scope of the organoids market report is mainly divided into five regions: North America, Asia Pacific, Europe, and the Middle East & Africa.
North America dominates the organoids market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. Organoids have the potential to overcome several previous limitations in biomedical research aimed at gaining mechanistic insights into human development, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. In 2023, researchers at the Wyss Institute at Harvard University and Duke University collaborated with Gameto to develop a human ovarian organoid that supports egg cell maturation and leads to new treatments for conditions such as infertility and ovarian cancer. The technology was licensed to Gameto in 2022 and is being used to develop therapeutics for diseases associated with the female reproductive system. Moreover, the US witnessed a rise in research activities on organoids. For instance, the Center for Stem Cell and Organoid Medicine (CuSTOM) at Cincinnati Children's Hospital is advancing personalized regenerative therapies using innovative stem cell technologies and organoids. The goal of the research is to engineer patient-specific, organoid-derived tissues for therapeutic transplantation. Thus, owing to the increasing research and development activities, rising need for tissue engineering and organ transplantation, and high adoption rate of organoids, the demand for organoids is expected to grow in the US during the forecast period.
Organoids Market Report Scope
Organoids Market News and Recent Developments
The organoids market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- The government of Canada announced the opening of STEMCELL Technologies' new state-of-the-art facility in Burnaby, British Columbia. The investment allowed STEMCELL Technologies to build a new biomanufacturing facility meeting higher regulatory standards. This will support clinical trials for various medical treatments with the goal of finding cures for cancer and other serious diseases. (STEMCELL Technologies, Press Release, July 2024)
Organoids Market Report Coverage and Deliverables
The "Organoids Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Organoids market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Organoids market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Organoids market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the organoids market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Organ Type, Application, Source, Type, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Strategic initiatives by companies would bring attractive trends in the market in the coming years.
Factors contributing to the organoids market growth include the increasing demand for tumor modeling and biobanking, and a surging adoption of personalized drugs.
North America dominated the market in 2023.
The market is expected to register a CAGR of 22.3% during 2023–2031.
The estimated value of the market would be US$ 15.01 billion by 2031.
STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KgaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation are among the key players in the market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 PEST Analysis
4. Organoids Market – Key Market Dynamics
4.1 Organoids Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Demand for Tumor Modeling and Biobanking
4.2.2 Surging Adoption of Personalized Drugs
4.3 Market Restraints
4.3.1 Dearth of Skilled Professionals
4.4 Market Opportunities
4.4.1 Focus on Drug Discovery Activities
4.5 Future Trends
4.5.1 Combination of Organoids and Organ-on-a-Chip
4.6 Impact of Drivers and Restraints:
5. Organoids Market – Global Market Analysis
5.1 Organoids Market Revenue (US$ Million), 2021–2031
5.2 Organoids Market Forecast Analysis
6. Organoids Market Analysis – by Type
6.1 Intestine
6.1.1 Overview
6.1.2 Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Liver
6.2.1 Overview
6.2.2 Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Pancreas
6.4.1 Overview
6.4.2 Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.5 Lung
6.5.1 Overview
6.5.2 Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Brain
6.6.1 Overview
6.6.2 Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Kidney
6.7.1 Overview
6.7.2 Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7. Organoids Market Analysis – by Application
7.1 Developmental Biology Disease
7.1.1 Overview
7.1.2 Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Pathology of Infectious Disease
7.2.1 Overview
7.2.2 Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Regenerative Medicine
7.3.1 Overview
7.3.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
7.4.1 Overview
7.4.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
7.5.1 Overview
7.5.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8. Organoids Market Analysis – by Source
8.1 Pluripotent Stem Cells
8.1.1 Overview
8.1.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Organ Specific Adult Stem Cell
8.2.1 Overview
8.2.2 Organ Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9. Organoids Market Analysis – by Offerings
9.1 Instruments
9.1.1 Overview
9.1.2 Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Consumables
9.2.1 Overview
9.2.2 Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Services
9.3.1 Overview
9.3.2 Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10. Organoids Market Analysis – by Method
10.1 Micropatterned Plates
10.1.1 Overview
10.1.2 Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Ultralow Attachment Plates
10.2.1 Overview
10.2.2 Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Hanging Drop
10.3.1 Overview
10.3.2 Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Microdroplet/Emulsion
10.4.1 Overview
10.4.2 Microdroplet/Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11. Organoids Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Organoids Market Overview
11.2.2 North America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3 North America: Organoids Market Breakdown, by Type
11.2.3.1 North America: Organoids Market – Revenue and Forecast Analysis – by Type
11.2.4 North America: Organoids Market Breakdown, by Application
11.2.4.1 North America: Organoids Market – Revenue and Forecast Analysis – by Application
11.2.5 North America: Organoids Market Breakdown, by Source
11.2.5.1 North America: Organoids Market – Revenue and Forecast Analysis – by Source
11.2.6 North America: Organoids Market Breakdown, by Offerings
11.2.6.1 North America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.2.7 North America: Organoids Market Breakdown, by Method
11.2.7.1 North America: Organoids Market – Revenue and Forecast Analysis – by Method
11.2.8 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.1 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.2 United States: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.2.1 United States: Organoids Market Breakdown, by Type
11.2.8.2.2 United States: Organoids Market Breakdown, by Application
11.2.8.2.3 United States: Organoids Market Breakdown, by Source
11.2.8.2.4 United States: Organoids Market Breakdown, by Offerings
11.2.8.2.5 United States: Organoids Market Breakdown, by Method
11.2.8.3 Canada: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.3.1 Canada: Organoids Market Breakdown, by Type
11.2.8.3.2 Canada: Organoids Market Breakdown, by Application
11.2.8.3.3 Canada: Organoids Market Breakdown, by Source
11.2.8.3.4 Canada: Organoids Market Breakdown, by Offerings
11.2.8.3.5 Canada: Organoids Market Breakdown, by Method
11.2.8.4 Mexico: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.4.1 Mexico: Organoids Market Breakdown, by Type
11.2.8.4.2 Mexico: Organoids Market Breakdown, by Application
11.2.8.4.3 Mexico: Organoids Market Breakdown, by Source
11.2.8.4.4 Mexico: Organoids Market Breakdown, by Offerings
11.2.8.4.5 Mexico: Organoids Market Breakdown, by Method
11.3 Europe
11.3.1 Europe Organoids Market Overview
11.3.2 Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3 Europe: Organoids Market Breakdown, by Type
11.3.3.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Type
11.3.4 Europe: Organoids Market Breakdown, by Application
11.3.4.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Application
11.3.5 Europe: Organoids Market Breakdown, by Source
11.3.5.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Source
11.3.6 Europe: Organoids Market Breakdown, by Offerings
11.3.6.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.3.7 Europe: Organoids Market Breakdown, by Method
11.3.7.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Method
11.3.8 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.2 Germany: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.2.1 Germany: Organoids Market Breakdown, by Type
11.3.8.2.2 Germany: Organoids Market Breakdown, by Application
11.3.8.2.3 Germany: Organoids Market Breakdown, by Source
11.3.8.2.4 Germany: Organoids Market Breakdown, by Offerings
11.3.8.2.5 Germany: Organoids Market Breakdown, by Method
11.3.8.3 France: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.3.1 France: Organoids Market Breakdown, by Type
11.3.8.3.2 France: Organoids Market Breakdown, by Application
11.3.8.3.3 France: Organoids Market Breakdown, by Source
11.3.8.3.4 France: Organoids Market Breakdown, by Offerings
11.3.8.3.5 France: Organoids Market Breakdown, by Method
11.3.8.4 United Kingdom: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.4.1 United Kingdom: Organoids Market Breakdown, by Type
11.3.8.4.2 United Kingdom: Organoids Market Breakdown, by Application
11.3.8.4.3 United Kingdom: Organoids Market Breakdown, by Source
11.3.8.4.4 United Kingdom: Organoids Market Breakdown, by Offerings
11.3.8.4.5 United Kingdom: Organoids Market Breakdown, by Method
11.3.8.5 Italy: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.5.1 Italy: Organoids Market Breakdown, by Type
11.3.8.5.2 Italy: Organoids Market Breakdown, by Application
11.3.8.5.3 Italy: Organoids Market Breakdown, by Source
11.3.8.5.4 Italy: Organoids Market Breakdown, by Offerings
11.3.8.5.5 Italy: Organoids Market Breakdown, by Method
11.3.8.6 Spain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.6.1 Spain: Organoids Market Breakdown, by Type
11.3.8.6.2 Spain: Organoids Market Breakdown, by Application
11.3.8.6.3 Spain: Organoids Market Breakdown, by Source
11.3.8.6.4 Spain: Organoids Market Breakdown, by Offerings
11.3.8.6.5 Spain: Organoids Market Breakdown, by Method
11.3.8.7 Rest of Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.7.1 Rest of Europe: Organoids Market Breakdown, by Type
11.3.8.7.2 Rest of Europe: Organoids Market Breakdown, by Application
11.3.8.7.3 Rest of Europe: Organoids Market Breakdown, by Source
11.3.8.7.4 Rest of Europe: Organoids Market Breakdown, by Offerings
11.3.8.7.5 Rest of Europe: Organoids Market Breakdown, by Method
11.4 Asia Pacific
11.4.1 Asia Pacific Organoids Market Overview
11.4.2 Asia Pacific: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3 Asia Pacific: Organoids Market Breakdown, by Type
11.4.3.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Type
11.4.4 Asia Pacific: Organoids Market Breakdown, by Application
11.4.4.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Application
11.4.5 Asia Pacific: Organoids Market Breakdown, by Source
11.4.5.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Source
11.4.6 Asia Pacific: Organoids Market Breakdown, by Offerings
11.4.6.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.4.7 Asia Pacific: Organoids Market Breakdown, by Method
11.4.7.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Method
11.4.8 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.2 Japan: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.2.1 Japan: Organoids Market Breakdown, by Type
11.4.8.2.2 Japan: Organoids Market Breakdown, by Application
11.4.8.2.3 Japan: Organoids Market Breakdown, by Source
11.4.8.2.4 Japan: Organoids Market Breakdown, by Offerings
11.4.8.2.5 Japan: Organoids Market Breakdown, by Method
11.4.8.3 China: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.3.1 China: Organoids Market Breakdown, by Type
11.4.8.3.2 China: Organoids Market Breakdown, by Application
11.4.8.3.3 China: Organoids Market Breakdown, by Source
11.4.8.3.4 China: Organoids Market Breakdown, by Offerings
11.4.8.3.5 China: Organoids Market Breakdown, by Method
11.4.8.4 India: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.4.1 India: Organoids Market Breakdown, by Type
11.4.8.4.2 India: Organoids Market Breakdown, by Application
11.4.8.4.3 India: Organoids Market Breakdown, by Source
11.4.8.4.4 India: Organoids Market Breakdown, by Offerings
11.4.8.4.5 India: Organoids Market Breakdown, by Method
11.4.8.5 South Korea: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.5.1 South Korea: Organoids Market Breakdown, by Type
11.4.8.5.2 South Korea: Organoids Market Breakdown, by Application
11.4.8.5.3 South Korea: Organoids Market Breakdown, by Source
11.4.8.5.4 South Korea: Organoids Market Breakdown, by Offerings
11.4.8.5.5 South Korea: Organoids Market Breakdown, by Method
11.4.8.6 Australia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.6.1 Australia: Organoids Market Breakdown, by Type
11.4.8.6.2 Australia: Organoids Market Breakdown, by Application
11.4.8.6.3 Australia: Organoids Market Breakdown, by Source
11.4.8.6.4 Australia: Organoids Market Breakdown, by Offerings
11.4.8.6.5 Australia: Organoids Market Breakdown, by Method
11.4.8.7 Rest of APAC: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.7.1 Rest of APAC: Organoids Market Breakdown, by Type
11.4.8.7.2 Rest of APAC: Organoids Market Breakdown, by Application
11.4.8.7.3 Rest of APAC: Organoids Market Breakdown, by Source
11.4.8.7.4 Rest of APAC: Organoids Market Breakdown, by Offerings
11.4.8.7.5 Rest of APAC: Organoids Market Breakdown, by Method
11.5 Middle East and Africa
11.5.1 Middle East and Africa Organoids Market Overview
11.5.2 Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3 Middle East and Africa: Organoids Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Type
11.5.4 Middle East and Africa: Organoids Market Breakdown, by Application
11.5.4.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Application
11.5.5 Middle East and Africa: Organoids Market Breakdown, by Source
11.5.5.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Source
11.5.6 Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.6.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.5.7 Middle East and Africa: Organoids Market Breakdown, by Method
11.5.7.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Method
11.5.8 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.2 Saudi Arabia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.2.1 Saudi Arabia: Organoids Market Breakdown, by Type
11.5.8.2.2 Saudi Arabia: Organoids Market Breakdown, by Application
11.5.8.2.3 Saudi Arabia: Organoids Market Breakdown, by Source
11.5.8.2.4 Saudi Arabia: Organoids Market Breakdown, by Offerings
11.5.8.2.5 Saudi Arabia: Organoids Market Breakdown, by Method
11.5.8.3 South Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.3.1 South Africa: Organoids Market Breakdown, by Type
11.5.8.3.2 South Africa: Organoids Market Breakdown, by Application
11.5.8.3.3 South Africa: Organoids Market Breakdown, by Source
11.5.8.3.4 South Africa: Organoids Market Breakdown, by Offerings
11.5.8.3.5 South Africa: Organoids Market Breakdown, by Method
11.5.8.4 United Arab Emirates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.4.1 United Arab Emirates: Organoids Market Breakdown, by Type
11.5.8.4.2 United Arab Emirates: Organoids Market Breakdown, by Application
11.5.8.4.3 United Arab Emirates: Organoids Market Breakdown, by Source
11.5.8.4.4 United Arab Emirates: Organoids Market Breakdown, by Offerings
11.5.8.4.5 United Arab Emirates: Organoids Market Breakdown, by Method
11.5.8.5 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type
11.5.8.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application
11.5.8.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source
11.5.8.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.8.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Method
11.6 South and Central America
11.6.1 South and Central America Organoids Market Overview
11.6.2 South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.3 South and Central America: Organoids Market Breakdown, by Type
11.6.3.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Type
11.6.4 South and Central America: Organoids Market Breakdown, by Application
11.6.4.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Application
11.6.5 South and Central America: Organoids Market Breakdown, by Source
11.6.5.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Source
11.6.6 South and Central America: Organoids Market Breakdown, by Offerings
11.6.6.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.6.7 South and Central America: Organoids Market Breakdown, by Method
11.6.7.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Method
11.6.8 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.2 Brazil: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.2.1 Brazil: Organoids Market Breakdown, by Type
11.6.8.2.2 Brazil: Organoids Market Breakdown, by Application
11.6.8.2.3 Brazil: Organoids Market Breakdown, by Source
11.6.8.2.4 Brazil: Organoids Market Breakdown, by Offerings
11.6.8.2.5 Brazil: Organoids Market Breakdown, by Method
11.6.8.3 Argentina: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.3.1 Argentina: Organoids Market Breakdown, by Type
11.6.8.3.2 Argentina: Organoids Market Breakdown, by Application
11.6.8.3.3 Argentina: Organoids Market Breakdown, by Source
11.6.8.3.4 Argentina: Organoids Market Breakdown, by Offerings
11.6.8.3.5 Argentina: Organoids Market Breakdown, by Method
11.6.8.4 Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type
11.6.8.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application
11.6.8.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source
11.6.8.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offerings
11.6.8.4.5 Rest of South and Central America: Organoids Market Breakdown, by Method
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 STEMCELL Technologies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Molecular Devices, LLC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merck KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACRO Biosystems.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SUN bioscience SA
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Crown Bioscience Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Sartorius AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 3D Biotek LLC
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Prellis Biologics Inc.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 3Dnamics Inc.
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Cellesce Ltd
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Organoids Market Segmentation
Table 2. Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Source
Table 6. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Offerings
Table 7. Organoids Market – Revenue and Forecast to 2031 (US$ Million) – by Method
Table 8. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 9. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 11. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 12. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 13. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 14. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 15. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 16. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 17. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 18. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 19. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 20. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 22. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 23. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 24. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 25. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 26. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 27. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 28. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 29. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 30. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 32. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 33. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 34. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 35. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 36. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 38. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 39. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 40. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 41. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 43. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 44. France: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 45. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 46. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 48. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 49. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 50. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 51. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 52. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 53. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 54. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 55. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 56. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 57. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 58. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 59. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 60. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 61. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 63. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 64. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 65. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 66. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 67. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 68. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 69. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 70. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 71. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 72. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 73. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 74. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 75. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 76. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 77. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 79. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 80. China: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 81. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 82. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 83. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 84. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 85. India: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 86. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 87. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 89. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 90. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 91. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 92. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 93. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 94. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 95. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 96. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 97. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 99. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 100. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 101. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 102. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 103. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 104. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 105. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 106. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 107. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 108. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 109. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 110. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 111. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 112. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 113. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 114. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 115. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 116. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 117. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 118. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 119. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 120. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 121. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 122. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 123. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 124. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 125. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 126. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 127. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 128. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 129. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 130. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 131. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 132. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 133. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 134. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 135. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 136. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 137. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 138. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 139. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 140. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 141. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 142. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 143. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 144. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 145. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 146. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Offerings
Table 147. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million) – by Method
Table 148. Recent Organic Growth Strategies in Organoids Market
Table 149. Recent Inorganic Growth Strategies in the Organoids Market
List of Figures
Figure 1. Organoids Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organoids Market Revenue (US$ Million), 2021–2031
Figure 5. Organoids Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Organoids Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Organoids Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Organoids Market Share (%) – by Offerings (2023 and 2031)
Figure 25. Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Organoids Market Share (%) – by Method (2023 and 2031)
Figure 29. Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 32. Microdroplet/Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 33. Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%)
Figure 35. North America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 39. North America: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 40. North America: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 41. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 42. United States: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Canada: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Mexico: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Europe: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 47. Europe: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 48. Europe: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 49. Europe: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 50. Europe: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 51. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Germany: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. France: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Kingdom: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Italy: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Spain: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. Rest of Europe: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Asia Pacific: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 60. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 61. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 62. Asia Pacific: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 63. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 64. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 65. Japan: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 66. China: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. India: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. South Korea: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. Australia: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Rest of APAC: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 73. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 74. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 75. Middle East and Africa: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 76. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 77. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 78. Saudi Arabia: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 79. South Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 80. United Arab Emirates: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 81. Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 82. South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 83. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031)
Figure 84. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031)
Figure 85. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031)
Figure 86. South and Central America: Organoids Market Breakdown, by Offerings (2023 and 2031)
Figure 87. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031)
Figure 88. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 89. Brazil: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 90. Argentina: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 91. Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031(US$ Million)
Figure 92. Growth Strategies in Organoids Market
The List of Companies - Organoids Market
- STEMCELL Technologies
- Molecular Devices, LLC.
- HUB Organoids B.V. (Hubrecht Organoid Technology)
- DefiniGEN
- Organoid Therapeutics
- Thermo Fisher Scientific Inc.
- Corning Inc.
- Merck KGaA
- InSphero
- ACRO Biosystems
- Bio-Techne Corporation.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For